Literature DB >> 2474458

The noncompetitive blocker [(3)H]chlorpromazine labels segment M2 but not segment M1 of the nicotinic acetylcholine receptor alpha-subunit.

J Giraudat1, J Gali, F Revah, J Changeux, P Haumont, F Lederer.   

Abstract

The membrane bound acetylcholine receptor from Torpedo marmorata was photolabeled by the noncompetitive channel blocker ]3H]chlorpromazine under equilibrium conditions in the presence of the agonist carbamoylcholine. The radioactivity incorporated into the AChR subunits was reduced by addition of phencyclidine, a specific ligand for the high-affinity side for noncompetitive blockers. The alpha-subunit was purified and digested with trypsin and/or CNBr and the resulting fragments fractionated by HPLC. Sequence analysis resulted in the identification of Ser-248 as a major residue labeled by [3H]chlorpromazine in a phencyclidine-sensitive manner. This residue is located in the hydrophobic and putative transmembrane segment M2 of the alpha-subunit, a region homologous to that containing the chlorpromazine-labeled Ser-262 in the delta-chain [1] and Ser-254 and Leu-257 in the beta-chain [2]. Extended sequence analysis of the hydrophobic segment M1 further showed that no labeling-occurred in this region.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474458     DOI: 10.1016/0014-5793(89)80957-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Inherited and experimentally induced changes in gating kinetics of muscle nicotinic acetylcholine receptor.

Authors:  C Bouzat; F J Barrantes
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

2.  Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ.

Authors:  V A Eterović; R Lu; A E Eakin; A D Rodríguez; P A Ferchmin
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

Review 3.  Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels.

Authors:  A Devillers-Thiéry; J L Galzi; J L Eiselé; S Bertrand; D Bertrand; J P Changeux
Journal:  J Membr Biol       Date:  1993-11       Impact factor: 1.843

4.  Allosteric binding site in a Cys-loop receptor ligand-binding domain unveiled in the crystal structure of ELIC in complex with chlorpromazine.

Authors:  Mieke Nys; Eveline Wijckmans; Ana Farinha; Özge Yoluk; Magnus Andersson; Marijke Brams; Radovan Spurny; Steve Peigneur; Jan Tytgat; Erik Lindahl; Chris Ulens
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-10       Impact factor: 11.205

5.  The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor gamma subunit: implications for the alpha-helical organization of regions MII and for the structure of the ion channel.

Authors:  F Revah; J L Galzi; J Giraudat; P Y Haumont; F Lederer; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Inhibition and Ultraviolet-Induced Chemical Modification of UDP-Glucose:(1,3)-beta-Glucan (Callose) Synthase by Chlorpromazine : Mechanism of Chlorpromazine Binding to the Plant Plasma Membrane.

Authors:  R W Harriman; A P Shao; B P Wasserman
Journal:  Plant Physiol       Date:  1992-12       Impact factor: 8.340

7.  Inhibition of the nicotinic acetylcholine receptor by barbiturates and by procaine: do they act at different sites?

Authors:  C S Yost; B A Dodson
Journal:  Cell Mol Neurobiol       Date:  1993-04       Impact factor: 5.046

8.  [(3)H]chlorpromazine photolabeling of the torpedo nicotinic acetylcholine receptor identifies two state-dependent binding sites in the ion channel.

Authors:  David C Chiara; Ayman K Hamouda; Michael R Ziebell; Luis A Mejia; Galo Garcia; Jonathan B Cohen
Journal:  Biochemistry       Date:  2009-10-27       Impact factor: 3.162

9.  Mutations in the M1 region of the nicotinic acetylcholine receptor alter the sensitivity to inhibition by quinacrine.

Authors:  S Tamamizu; A P Todd; M G McNamee
Journal:  Cell Mol Neurobiol       Date:  1995-08       Impact factor: 5.046

10.  Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain.

Authors:  D Bertrand; A Devillers-Thiéry; F Revah; J L Galzi; N Hussy; C Mulle; S Bertrand; M Ballivet; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.